Evidence map›Paper›PMID 38136680›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Performance and Impact on Antibiotic Prescriptions of a Multiplex PCR in a Real-Life Cohort of Critically Ill Patients with Suspected Ventilated Pneumonia: A Retrospective Monocentric Observational Study.

Emma Chambe, Perrine Bortolotti, Rémy Diesnis, Caroline Laurans, Rozenn Héquette-Ruz, Sophie Panaget, Patrick Herbecq, Anne Vachée, Agnès Meybeck

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emma ChambeDepartment of Critical Care, Victor Provo Hospital, 59100 Roubaix, France.
Perrine BortolottiDepartment of Critical Care, Victor Provo Hospital, 59100 Roubaix, France.
Rémy DiesnisDepartment of Biostatistics, Victor Provo Hospital, 59100 Roubaix, France.ORCID 0000-0001-7938-4091
Caroline LauransInfectious Risk Management Unit, Victor Provo Hospital, 59100 Roubaix, France.
Rozenn Héquette-RuzInfectious Risk Management Unit, Victor Provo Hospital, 59100 Roubaix, France.
Sophie PanagetInfectious Risk Management Unit, Victor Provo Hospital, 59100 Roubaix, France.
Patrick HerbecqDepartment of Critical Care, Victor Provo Hospital, 59100 Roubaix, France.
Anne VachéeDepartment of Microbiology, Victor Provo Hospital, 59100 Roubaix, France.
Agnès MeybeckInfectious Risk Management Unit, Victor Provo Hospital, 59100 Roubaix, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary multiplex polymerase chain reaction (m-PCR) allows rapid pathogen detection. We aimed to assess its impact on initial antibiotic prescriptions in ventilated patients with suspected pneumonia. Between November 2020 and March 2022,ventilated patients with suspected pneumonia hospitalized in our ICU who benefited from respiratory sampling simultaneously tested using conventional microbiological methods and m-PCR were included. The proportion of appropriate changes in the initial antibiotic therapy following m-PCR results was assessed. We analyzed 104 clinical samples. Of the 47 negative m-PCR results, 16 (34%) led to an appropriate antibiotic strategy: 8 cessationsand 8 lack of initiation. Of the 57 positive m-PCR results, 51 (89%) resulted in an appropriate antibiotic strategy: 33 initiations, 2 optimizations, and 9 de-escalations. In the multivariate analysis, a positive m-PCR was associated with an appropriate antibiotic change (OR: 96.60; IC95% [9.72; 960.20],

Indexed as

antibiotic useCOVID-19intensive caremultiplex PCRpneumonia

Identifiers

PMID38136680
PMCPMC10741159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.